Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amphastar Pharmaceuticals (DE:29A)
FRANKFURT:29A
RESEARCH TOOLSreports
Holding DE:29A?
Track your performance easily
| Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 182.39M | $ 171.84M | $ 178.10M | $ 180.56M | $ 72.74M |
| Gross Profit | $ 95.17M | $ 90.10M | $ 96.14M | $ 108.40M | $ 72.74M |
| EBIT | $ 50.24M | $ 55.91M | $ 50.80M | $ 77.34M | $ 36.11M |
| EBITDA | $ 66.82M | $ 72.00M | $ 64.59M | $ 96.15M | $ 46.38M |
| Net Income Common Stockholders | $ 37.95M | $ 43.18M | $ 36.17M | $ 49.22M | $ 26.12M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 217.78M | $ 289.56M | $ 256.81M | $ 299.88M | $ 165.84M |
| Total Assets | $ 1.49B | $ 1.57B | $ 1.51B | $ 1.54B | $ 1.38B |
| Total Debt | $ 620.58M | $ 627.12M | $ 623.64M | $ 672.56M | $ 528.74M |
| Net Debt | $ 402.81M | $ 337.56M | $ 366.84M | $ 372.68M | $ 362.90M |
| Total Liabilities | $ 778.18M | $ 901.96M | $ 873.49M | $ 949.49M | $ 789.03M |
| Stockholders Equity | $ 713.35M | $ 672.36M | $ 639.42M | $ 595.14M | $ 589.24M |
| Cash Flow | - | ||||
| Free Cash Flow | $ 63.06M | $ 46.50M | $ 14.42M | $ 54.14M | $ 45.87M |
| Operating Cash Flow | $ 69.11M | $ 55.29M | $ 23.86M | $ 64.33M | $ 54.92M |
| Investing Cash Flow | $ -69.90M | $ 15.24M | $ -103.05M | $ -31.15M | $ -508.58M |
| Financing Cash Flow | $ -10.72M | $ -13.58M | $ -47.08M | $ 86.61M | $ 428.11M |